Novavax, Inc (NVAX) Volatility Spurs A Quest For Clarity
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of 22.08% and -6.18% over the past three months. NVAX shares are trading -3.73% year to date (YTD), with the 12-month market performance down to -40.00% lower. […]
These Numbers Could Change Investor Views For Novavax, Inc (NASDAQ: NVAX)
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -6.79% and -26.51% over the past three months. NVAX shares are trading -25.68% year to date (YTD), with the 12-month market performance up to 29.61% higher. […]
Handle With Care: Novavax, Inc (NASDAQ: NVAX)
Currently, there are 160.42M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -5.45% and -28.04% over the past three months. NVAX shares are trading -24.50% year to date (YTD), with the 12-month market performance up to 28.87% higher. […]
Novavax, Inc (NVAX): A Great Stock For Handling Current Market Conditions?
Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 11.17% and -27.66% over the past three months. NVAX shares are trading -17.04% year to date (YTD), with the 12-month market performance up to 59.19% higher. […]
Technical Outlook And Game Plan For Novavax, Inc (NASDAQ: NVAX)
Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $7.47, with 14.72 million shares of worth about $109.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.62% during that period and on April 23, 2025 the price saw a gain […]
Why Should You Put Novavax, Inc (NASDAQ: NVAX) On Your Portfolio?
Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 1.27% and -24.87% over the past three months. NVAX shares are trading -20.52% year to date (YTD), with the 12-month market performance up to 49.30% higher. […]
Some Investing Thoughts On Novavax, Inc (NASDAQ: NVAX)
Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $5.43, with 22.43 million shares of worth about $121.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -58.36% during that period and on April 10, 2025 the price saw a loss […]
Gains May Be On The Menu For Novavax, Inc (NASDAQ: NVAX)
Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of -20.63% and -27.54% over the past three months. NVAX shares are trading -25.37% year to date (YTD), with the 12-month market performance up to 25.52% higher. […]
Novavax, Inc (NASDAQ: NVAX) Stock In Prove Me State
Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $7.26, with 2.6 million shares of worth about $18.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.37% during that period and on March 27, 2025 the price saw a loss […]
Novavax, Inc (NVAX) Testing Investors’ Patience Right Now
Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 0.38% and -11.86% over the past three months. NVAX shares are trading -1.12% year to date (YTD), with the 12-month market performance up to 59.64% higher. […]
